ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2022 Earnings Call Transcript

And we’ve been very grateful for that. And so some of the people that we have in our list of collaborations have also strong relationships with GE, so opening the door for us in a way has been very helpful. But I also want to emphasize that ENDRA also wants to stand alone for the sake of its investors. We’re very, very small. We’re grateful to GE but we want to control our own destiny and certainly beyond radiology which is GE’s focus. ENDRA sees a growing opportunity in hepatology, the liver experts who don’t currently use much ultrasound. And even beyond that to the fast growing field of endocrinology, again, a field that is booming due to the obesity epidemic. People focused on metabolism, liver and other health, but they don’t use a lot of ultrasound.

So we view that as an opportunity beyond GE to leverage our small commercial team to build relationships as we’ve been doing, going to clinical conferences and demonstrating that. And so we view this hybrid relationship of working with GE, long-term, having them as a partner in radiology and then being able to guide ourselves very accurately beyond radiology we think is a benefit to ourselves and to investors. I hope that helps.

Edward Woo: That’s very helpful. Thank you. And I wish you guys good luck. Thank you.

Francois Michelon: Thank you so much, Ed.

Francois Michelon: Operator, if we don’t have any more questions, I think we’ll close the call. So I want to thank all our listeners and the ENDRA team for participating today and we look forward to keeping you updated and speaking with you on our next quarterly call. Have a good evening.

Operator: The conference is now concluded. Thank you for attending today’s presentation. You may now disconnect.